Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug approval
Pharma
Takeda wins FDA nod for first-in-class blood cancer drug Mimrylo
One of three key launches for Takeda's next phase of growth, Mimrylo is the first drug for polycythemia vera that mimics hepcidin.
Angus Liu
Aug 28, 2026 10:04pm
Gilead crosses FDA finish line with new HIV combo pill
Aug 27, 2026 5:56pm
BMS bags first FDA approval for CELMoD franchise with Zenbexus
Aug 14, 2026 10:09am
FDA approves Takeda's first-in-class Orzeyful for narcolepsy
Aug 6, 2026 11:10am
FDA approves Otsuka’s first-in-class ADHD drug Simtriyo
Jul 27, 2026 12:42pm
Vera’s dual-target atacicept wins FDA approval for IgAN
Jul 7, 2026 12:23pm
